1. The Defendant is liable to pay the Plaintiff’s insurance proceeds to the Defendant, claiming on July 11, 2018 based on the attached insurance contract.

1. The following facts are recognized as either a dispute between the parties or in full view of the evidence set forth in subparagraphs A(1) through (8) and the purport of the entire pleadings.

A. On August 25, 2010, the Defendant concluded an attached Table 1 insurance contract with the Plaintiff (hereinafter “instant insurance contract”).

B. Of the insurance terms and conditions incorporated into the instant insurance contract, the issues of the instant case are as shown in attached Form 2.

C. On November 14, 2014, the Defendant, at the E Hospital located in Seongbuk-gu, Sungnam-si, was found to undergo an internal inspection of the workplace, and received sprinkling sprinkling sprinklings. D.

The results of the organizational pathology test (hereinafter "the results of the organizational pathology test of this case") that the Defendant is considered to be the Grade 1 (Nuroendiodede 1) of the Nurinor Grade on November 20, 2014 after conducting the organizational pathology test of the E Hospital for the Defendant.

2) On November 21, 2014, G, a medical doctor, and a medical doctor, within the fire extinguisher of the E Hospital, was drafted, and on November 21, 2014, the Defendant: (a) the following (hereinafter referred to as “instant medical certificate”).

The Defendant issued the instant insurance proceeds on November 26, 2014, on the ground that the form of action at a name-based workplace is unclear or that the Defendant was diagnosed and removed from the treatment content D37.5 of the U.S. No. 437.5 of the U.S. E. E. The result of the organizational pathology test was observed. E. The Defendant claimed the instant insurance proceeds on the ground that the Plaintiff was diagnosed as “the form of action at work or the unknown and unknown new organisms” along with the instant diagnosis report and the result of the organizational pathology test, and on November 26, 2014, the Plaintiff paid the Defendant KRW 10,000,000 in total of the insurance proceeds corresponding to the boundary species (the main contract border type diagnosis benefits of KRW 3,000,000,000 in a specific border type diagnosis benefits of KRW 7,700,000.

F. On July 11, 2018, the Defendant attached the instant diagnosis certificate and the result of organizational pathology examination to the Defendant’s pathy.